Synthetic Design Lab
Precision by Design
South San Francisco, United States · Founded 2024 · $20.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- syntheticdesignlab.com
- Total Funding
- $20.0M
- Last Round
- $20.0M SeedApr 2025
- Rounds
- 1
About
Synthetic Design Lab is a next-generation antibody-drug conjugate (ADC) biotech company based in the San Francisco Bay Area, building cancer therapeutics on novel synthetic biology foundations. The company's proprietary SYNTHBODY platform enables synthetic targeting with multilayered logic control, achieving over 10x improvement in targeted cancer cell killing compared to conventional IgG-based ADCs. Founded by oncology veterans from Genentech and IGM Biosciences — including Dr. Daniel S. Chen, who led clinical development of atezolizumab (TECENTRIQ) — the company launched with a $20 million seed round in April 2025 and is advancing a pipeline of precision therapeutics for difficult-to-treat cancers.
Summary
Synthetic Design Lab is a Biotech company based in South San Francisco, United States, founded in 2024. It has raised $20.0M in total across 1 round, most recently a $20.0M Seed round in Apr 2025. Investors include Playground Global, Godfrey Capital and Goldcrest Capital.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...